Astellas Pharma Inc (OTC Pink - Current Information:ALPMY)

16.18
Delayed Data
As of Apr 27
 -0.15 / -0.92%
Today’s Change
10.87
Today|||52-Week Range
16.99
+15.89%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$35.6B

Company Description

Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products mainly target therapeutic fields such as transplantation, immunology, infectious diseases, urology, oncology, neuroscience, diabetic complications, and metabolic diseases. Its global brands include Prograf, Vesicare, Protopic, Harnal, and Funguard. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.

Contact Information

Astellas Pharma, Inc.
2-5-1 Nihonbashi-Honcho
Tokyo Tokyo 103-8411
P:(133) 244-3000
Investor Relations:
(133) 244-3271

Employees

Shareholders

Other institutional0.07%
Mutual fund holders0.01%
Individual stakeholders--

Top Executives

Yoshihiko HatanakaPresident & Representative Director
Yasumasa MasudaSenior Executive Officer & Head-Finance
Mitsunori MatsudaExecutive Officer & General Manager-Technology
Yasushi MiyazawaSenior Vice President & Global Head-Global Project
Yoshiro MiyokawaRepresentative Director, VP & Head-Compliance

To view my watchlist

Not a member yet?

Sign up now for a free account